Preparation method of target compound nano particle
A composite nanoparticle and nanoparticle technology, which can be used in medical preparations with non-active ingredients, wave energy or particle radiation treatment materials, medical preparations containing active ingredients, etc., can solve the problem of poor stability of anti-tumor drug carriers and drug loading Small amount and other problems, to achieve the effect of high feasibility, small side effects, and increase drug concentration
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0040] Specific embodiment 1: The preparation method of the targeted composite nanoparticles in this embodiment is carried out according to the following steps:
[0041] 1. Preparation of magnetic nanoparticles:
[0042] 10 mL of FeCl with a concentration of 1 mol / L 3 Aqueous solution, 2.5mL FeSO 4 ·7H 2 The HCl solution of O was added to 125 mL of NH with a concentration of 0.7 mol / L 3 ·7H 2 0, continue to stir for 30min, centrifuge and collect the product in the supernatant, the product in the supernatant is washed 3 times with deionized water, then be dispersed in 150mL deionized water again, obtain Fe 3 o 4 Nanoparticle solution;
[0043] The FeSO 4 ·7H 2 O in HCl solution FeSO 4 ·7H 2 The concentration of O is 2mol / L, and the concentration of HCl is 2mol / L;
[0044] 2. Preparation of Fe 3 o 4 -HCPT nanoparticles:
[0045] 10mLFe 3 o 4 Disperse the nanoparticle solution into 10ml of polyhydrochloroallylamine NaCl aqueous solution, ultrasonically react for 3...
specific Embodiment approach 2
[0066] Embodiment 2: This embodiment differs from Embodiment 1 in that in step 12, 0.03 g of 1,2-dimercapto-3-cyclohexyl polyethylene glycol and 3.5 ml of tetrahydrofuran are added to the centrifuge tube. Others are the same as in the first embodiment.
specific Embodiment approach 3
[0067] Specific embodiment three: the difference between this embodiment and specific embodiment one is that in step thirteen, 60mg~90mgFe 3 o 4 -HCPTSiO 2 A methanol solution of integrated nanoparticles coupled with a porphyrin-based photosensitizer, 10 mL of N,N-dimethylformamide, and 50 mg of targeted biomolecules or antitumor drugs were stirred and reacted at room temperature for 2 hours. Others are the same as in the first embodiment.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com